SCWorx Corp. (WORX) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
SCWorx Corp. (WORX) trades at $0.55 with AI Score 19/100 (Grade F). SCWorx Corp. provides healthcare information technology solutions, focusing on data normalization and interoperability. Sector: Healthcare.
Price as of Jul 23, 2026 · Last analyzed: Mar 17, 2026Analyst Coverage for WORX: WORX does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates WORX against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
WORX: 3/3 scored disciplines lean bearish. Dominant signal: Momentum weak.
How is this calculated? →Why this analysis is different
- A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
- An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
- Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.
SCWorx Corp. (WORX) Healthcare & Pipeline Overview
SCWorx Corp. delivers healthcare IT solutions, specializing in data normalization and interoperability for hospitals and healthcare facilities. The company's offerings include data analytics, EMR management, and a ticketing platform for mixed martial arts, positioning it as a diversified player in the healthcare information services sector.
What Is the Investment Thesis for WORX?
SCWorx Corp. operates in the healthcare information technology sector, a market with significant growth potential. The company's focus on data normalization and interoperability addresses a critical need for healthcare providers. However, with a market capitalization of $0.00B and negative profitability (P/E of -0.31 and Profit Margin of -139.7%), the company faces significant challenges. The high beta of 2.02 indicates high volatility. Growth catalysts include potential expansion of its data analytics services and increased adoption of its CageTix platform. The company's ability to achieve profitability and manage its operating expenses will be crucial for its long-term success. Investors should closely monitor the company's financial performance and its ability to execute its growth strategy.
Based on FMP financials and quantitative analysis
WORX Key Highlights
- Market Cap of $0.00B indicates a micro-cap company with limited resources and higher risk.
- P/E ratio of -0.31 reflects negative earnings and suggests the company is not currently profitable.
- Profit Margin of -139.7% indicates significant losses and operational inefficiencies.
- Gross Margin of 26.1% suggests some ability to generate revenue above the cost of goods sold, but needs improvement.
- Beta of 2.02 indicates the stock is more volatile than the market, suggesting higher risk.
Who Are WORX's Competitors?
WORX is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| CCM Concord Medical Services Holdings Limited | $4.22 | -2.09% | — | |
| COCH Envoy Medical, Inc. | $0.66 | -4.60% | $13.8M | — |
| NIVF NewGenIvf Group Limited | $1.22 | -3.94% | 43 | |
| CMHSF Comprehensive Healthcare Systems, Inc. | $0.34 | +0.00% | $6.22M | 55 |
| CRBKF Carebook Technologies Inc. | $0.03 | +0.00% | $6.84M | 64 |
| CMPD CompuMed, Inc. | $6.70 | -0.30% | $8.64M | 60 |
| BBLN Babylon Holdings Limited | $0.55 | -13.99% | $14.1M | 56 |
| THKKF Think Research Corporation | $0.23 | -1.74% | $17.8M | 57 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are WORX's Key Strengths?
- Specialized healthcare data normalization and interoperability solutions.
- Established relationships with hospitals and health systems.
- Proprietary CageTix ticketing platform for MMA events.
- Experience in navigating the healthcare IT landscape.
What Are WORX's Weaknesses?
- Low market capitalization and limited financial resources.
- Negative profitability and high operating expenses.
- High stock volatility.
- Reliance on a small number of employees.
What Could Drive WORX Stock Higher?
- Potential new contracts for data normalization and interoperability services.
- Expansion of the CageTix platform into new markets.
- Increased demand for healthcare data analytics solutions.
What Are the Key Risks for WORX?
- Financial-distress signal — its Altman Z-Score of -5.89 sits in the distress zone (elevated bankruptcy risk).
- Negative return on equity (-64.6%) — the business is not currently generating profit on shareholder capital.
- Intense competition in the healthcare IT market.
- Regulatory changes and compliance requirements.
- Negative profitability and high operating expenses.
- High stock volatility.
What Are the Growth Opportunities for WORX?
- Expansion of Data Analytics Services: SCWorx can leverage its data analytics capabilities to offer more comprehensive solutions to healthcare providers. The healthcare analytics market is projected to reach $75 billion by 2026, driven by the need for better patient outcomes and cost reduction. By focusing on predictive analytics and personalized medicine, SCWorx can capture a larger share of this market. Timeline: 2-3 years.
- Increased Adoption of CageTix Platform: The CageTix platform offers a unique opportunity to diversify revenue streams. The mixed martial arts (MMA) event ticketing market is growing, with regional events gaining popularity. By expanding the platform's reach and offering value-added services, SCWorx can increase its revenue from this segment. Timeline: 1-2 years.
- Strategic Partnerships and Acquisitions: SCWorx can pursue strategic partnerships with other healthcare IT providers to expand its product offerings and market reach. Acquisitions of complementary businesses can also accelerate growth. The healthcare IT market is consolidating, and strategic alliances can provide a competitive advantage. Timeline: Ongoing.
- Focus on Interoperability Solutions: With the increasing emphasis on interoperability in healthcare, SCWorx can focus on developing solutions that enable seamless data exchange between different healthcare systems. The interoperability market is expected to grow significantly, driven by regulatory mandates and the need for better care coordination. Timeline: 2-3 years.
- Sales of PPE and COVID-19 Test Kits: SCWorx's recent involvement in selling PPE and COVID-19 test kits presents a short-term revenue opportunity. While this is not a core business, it can provide additional revenue and cash flow during the pandemic. However, the company needs to manage this business carefully to avoid supply chain disruptions and quality issues. Timeline: Ongoing.
What Opportunities Does WORX Have?
- Expansion of data analytics services.
- Increased adoption of CageTix platform.
- Strategic partnerships and acquisitions.
- Focus on interoperability solutions.
What Threats Does WORX Face?
- Intense competition in the healthcare IT market.
- Regulatory changes and compliance requirements.
- Potential supply chain disruptions and quality issues related to PPE and COVID-19 test kits.
- Economic downturn affecting healthcare spending.
What Are WORX's Competitive Advantages?
- Specialized healthcare data normalization and interoperability solutions.
- Established relationships with hospitals and health systems.
- Proprietary CageTix ticketing platform for MMA events.
- Experience in navigating the healthcare IT landscape.
What Does WORX Do?
SCWorx Corp., based in Tampa, Florida, develops and markets healthcare information technology solutions designed to improve healthcare processes and information flow within hospitals and other healthcare facilities across the United States. The company's core offerings revolve around data content and services related to the repair, normalization, and interoperability of information for healthcare providers. SCWorx also provides big data analytics tailored for the healthcare industry, enabling providers to gain insights from their data. The company's solutions include virtualized item master file repair, expansion and automation, EMR (Electronic Medical Record) management, CDM (Charge Description Master) management, contract management, request for proposal automation, rebate management, integration of acquired management, big data analytics modeling, data integration and warehousing, and ScanWorx. SCWorx also operates CageTix, an online event ticketing platform focused on serving regional mixed martial arts events. In recent times, the company has also been involved in selling personal protective equipment (PPE) and COVID-19 rapid test kits. SCWorx sells its solutions and services through a direct sales force and through distribution and reseller partnerships, targeting hospitals and health systems.
What Products and Services Does WORX Offer?
- Develops healthcare information technology solutions.
- Markets solutions to improve healthcare processes and information flow.
- Provides data content and services for data repair and normalization.
- Offers big data analytics for the healthcare industry.
- Operates a virtualized item master file repair and automation service.
- Provides EMR and CDM management solutions.
- Operates an online event ticketing platform for mixed martial arts events.
- Sells personal protective equipment (PPE) and COVID-19 rapid test kits.
How Does WORX Make Money?
- Sells healthcare IT solutions and services to hospitals and health systems.
- Generates revenue from data normalization and interoperability services.
- Earns revenue from the CageTix ticketing platform.
- Generates revenue from sales of PPE and COVID-19 test kits.
What Industry Does WORX Operate In?
SCWorx Corp. operates within the healthcare information technology (IT) sector, which is experiencing substantial growth driven by the increasing adoption of digital health solutions, electronic health records (EHRs), and the need for improved data interoperability. The market is competitive, with established players like Cerner (now Oracle), Epic Systems, and smaller, specialized firms such as Computer Programs and Systems (CCM), Computer Task Group (CDT), and COCH focusing on niche areas. SCWorx's focus on data normalization and big data analytics positions it to capitalize on the growing demand for data-driven healthcare solutions.
Who Are WORX's Key Customers?
- Hospitals
- Health systems
- Healthcare providers
- Mixed martial arts event organizers and attendees
How SCWorx Corp. Is Valued
Relative to its peer group, WORX's quantitative score of 19/100 is below the peer average of 54/100.
ROE -65%Key Financial Metrics
Return on equity for SCWorx Corp. stands at -64.6%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -53.3%, showing how much profit it generates from its asset base. A current ratio of 2.53 indicates the company holds enough short-term assets to cover its near-term obligations.
F-Score 4/9Financial Health
SCWorx Corp.'s Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of -5.89 places it in the distress zone, a signal of elevated financial risk.
WORX Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in SCWorx's growth prospects, indicating that those closest to the company believe in its future.
- Community sentiment has been increasingly positive, with discussions highlighting the company's innovative solutions in data management.
- The recent expansion of partnerships in the healthcare sector has bolstered market perception, positioning SCWorx as a key player in a growing industry.
- Investors are optimistic about SCWorx's potential to capitalize on the increasing demand for efficient data solutions.
Bear Case
- Concerns about the company's financial stability have surfaced, with some investors questioning its ability to maintain profitability in the near term.
- Recent social media discussions show a divide, with a notable portion of the community expressing skepticism regarding SCWorx's long-term strategy.
- The competitive landscape in the data management sector is intensifying, raising fears that SCWorx may struggle to differentiate itself.
- Market sentiment has been tempered by broader economic uncertainties, leading some investors to adopt a more cautious approach towards SCWorx.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
WORX Latest News
No recent news available for WORX.
WORX Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for WORX.
Price Targets
Wall Street price target analysis for WORX.
WORX MoonshotScore
What does this score mean?
The MoonshotScore rates WORX 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Leadership: Timothy Andrew Hannibal
CEO
Information on Timothy Andrew Hannibal's background is not available in the provided data. Further research would be needed to determine his career history, education, previous roles, and credentials.
Track Record: Information on Timothy Andrew Hannibal's track record is not available in the provided data. Further research would be needed to determine his key achievements, strategic decisions, and company milestones under his leadership.
Common Questions About WORX (Healthcare)
What does the AI Score mean for WORX?
WORX holds an AI Score of 19/100 (Grade: F). This is an educational research signal, not a buy or sell recommendation. SCWorx Corp. provides healthcare information technology solutions, focusing on data normalization and interoperability. The company also operates a ticketing platform for mixed martial arts events …
What does SCWorx Corp. do?
SCWorx Corp. is a healthcare information technology company that develops and markets solutions to improve healthcare processes and information flow. The company's core offerings include data normalization, interoperability services, and big data analytics for healthcare providers.
What are the main risks for WORX?
SCWorx faces several risks, including intense competition in the healthcare IT market, regulatory changes and compliance requirements, and potential supply chain disruptions related to PPE and COVID-19 test kits. The company's negative profitability and high operating expenses also pose a significant risk. Additionally, the high stock volatility (beta of 2.02) could lead to substantial price swings. Investors should be aware of these risks before investing in SCWorx.
What are the key factors to evaluate for WORX?
SCWorx Corp. (WORX) holds an AI score of 19/100 (low). Not financial advice.
How frequently does WORX data refresh on this page?
WORX's price was last updated on Jul 23, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven WORX's recent stock price performance?
SCWorx Corp. (WORX) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Specialized healthcare data normalization and interoperability solutions. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider WORX overvalued or undervalued right now?
SCWorx Corp. (WORX) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research WORX before investing?
Before investing in SCWorx Corp. (WORX), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding WORX to a portfolio?
Key strength of SCWorx Corp. (WORX): Specialized healthcare data normalization and interoperability solutions. Weigh rewards against risks and diversify. Not financial advice.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is limited and may not be fully up-to-date.
- Information on CEO background and track record is unavailable.
- AI analysis is pending.